Publisher Correction: A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders

Nat Commun. 2023 Sep 28;14(1):6054. doi: 10.1038/s41467-023-41873-8.

Takenobu Katagiri^{1

2}, Sho Tsukamoto^{3

4}, Mai Kuratani³, Shinnosuke Tsuji⁵, Kensuke Nakamura⁶, Satoshi Ohte^{3

7}, Yoshiro Kawaguchi⁶, Kiyosumi Takaishi⁵

¹ Division of Biomedical Sciences, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1241, Japan. katagiri@saitama-med.ac.jp.
² Project of Clinical and Basic Research for FOP, Saitama Medical University, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1241, Japan. katagiri@saitama-med.ac.jp.
³ Division of Biomedical Sciences, Research Center for Genomic Medicine, Saitama Medical University, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1241, Japan.
⁴ Project of Clinical and Basic Research for FOP, Saitama Medical University, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1241, Japan.
⁵ Specialty Medicine Research Laboratories I, R&D Division, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.
⁶ Modality Research Laboratories, Biologics Division, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.
⁷ Graduate School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.

No abstract available

Publication types